The Journal of Commercial Biotechnology announces the publication of the July 2013 issue, featuring new papers on biotechnology management and commercialization.
Journal of Commercial Biotechnology Vol 19, Issue 3 (2013)
Patenting human genes and mutations: A personal perspective
Ananda Mohan Chakrabarty
Full details at the Journal of Commercial Biotechnology
The polyvalent scientist: the added value of management training
Maria Theodosiou, Arsia Amir-Aslani
The PhD is becoming more and more prevalent as a degree. However, PhD students are not adequately prepared for careers outside academia and most of them have trouble translating their skills to the job market. The biotech sector is a science-driven industry that is now mature and flourishing and requires business leaders that are technically trained…
Full details at the Journal of Commercial Biotechnology
A Role for Virtual Biotechnology Companies in Drug Discovery and Development?
Dianne Nicol, Johnathon Liddicoat, Christine Critchley
The orthodox business model of many drug discovery and development companies centres on adding value to early-stage discoveries prior to engaging with large pharmaceutical companies to bring products to market. Anecdotal observations suggest some companies are moving to a ‘virtual’ business model – instead of employing in-house scientists, a skeletal management team runs the company and out-sources all research and development…
Full details at the Journal of Commercial Biotechnology
The role of specialization in mutual fund investment strategies: An exploratory study of the life sciences industry.
Osne Frans Kirzner, Lorraine Marie Uhlaner
This paper explores possible differences in investment strategies between specialty and non-specialty funds in the life sciences industry…
Full details at the Journal of Commercial Biotechnology
Culture and the Principles of Biomedical Ethics
Kola Abimbola
This paper examines the roles of culture in the principles of biomedical ethics. Drawing on examples from African, Navajo and Western cultures, the paper maintains that various elements of culture are indispensable to the application of the principles of biomedical ethics. Full details at the
The relevance and importance of business development and licensing in the biopharmaceutical industry.
Roger Davies
The importance of the business development and licensing (BD&L) function in the global biopharmaceutical industry has grown significantly over the past 20 years as pharmaceutical companies have sought to supplement their internal R&D with innovative products and technologies sourced from biotechnology and drug delivery companies…
Full details at the Journal of Commercial Biotechnology
Patent Licensing Considerations for Biologics under the BPCIA
Sheila Swaroop, Carol Pitzel Cruz
Full details at the Journal of Commercial Biotechnology
Evergreening patents: The Indian Supreme Court rejects patenting of incremental improvements
Joanna Brougher
On April 1, 2013, the Supreme Court in India handed down its decision to dismiss Swiss drug maker Novartis AG’s attempt to win patent protection for its cancer drug Glivec…
Full details at the Journal of Commercial Biotechnology
The life sciences industry and the changing IP landscape
Gareth Williams
This article looks at the findings of Marks & Clerk’s 2013 Life Sciences Report, launched in April 2013. Of interest to both R&D/IP experts and professionals in strategic positions within biotechnology companies, it explores many of the issues facing the biotechnology industry and is informed by an industry survey of over 330 international life sciences professionals…
Full details at the Journal of Commercial Biotechnology
EU Legal & Regulatory Update
Ewan Grist
Full details at the Journal of Commercial Biotechnology
Book Review: The crowdfunding revolution: How to raise venture capital using social media
Steven S. Ma
Full details at the Journal of Commercial Biotechnology